Solitaire™ FR as Primary Treatment for Acute Ischemic Stroke (SWIFT PRIME)
This study is currently recruiting participants.
Verified March 2013 by Covidien
Sponsor:
Covidien
Information provided by (Responsible Party):
Covidien
ClinicalTrials.gov Identifier:
NCT01657461
First received: August 2, 2012
Last updated: March 6, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2018 |
| Estimated Primary Completion Date: | June 2018 (Final data collection date for primary outcome measure) |